Targeting head and neck cancer stem cells: Current advances and future challenges

A. C. Birkeland, J. H. Owen, M. E. Prince

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

Cancer stem cells (CSCs), or tumor-initiating cells, comprise a subset of tumor cells with demonstrated ability for tumor growth, invasion, metastasis, and resistance to chemotherapy and radiation. Targeting of CSCs remains an attractive yet elusive therapeutic option, with the goal of increasing specificity and effectiveness in tumor eradication, as well as decreasing off-target or systemic toxicity. Research into further characterization and targeted therapy toward head and neck CSCs is an active and rapidly evolving field. This review discusses the current state of research into therapy against head and neck CSCs and future directions for targeted therapy.

Original languageEnglish (US)
Pages (from-to)1516-1523
Number of pages8
JournalJournal of Dental Research
Volume94
Issue number11
DOIs
StatePublished - Nov 1 2015
Externally publishedYes

Fingerprint

Neoplastic Stem Cells
Head and Neck Neoplasms
Neoplasms
Therapeutics
Research
Radiation
Neoplasm Metastasis
Drug Therapy
Growth

Keywords

  • cancer biology
  • cancer genes
  • characteristics
  • HNSCC
  • treatment
  • tumor initiating cells

ASJC Scopus subject areas

  • Dentistry(all)

Cite this

Targeting head and neck cancer stem cells : Current advances and future challenges. / Birkeland, A. C.; Owen, J. H.; Prince, M. E.

In: Journal of Dental Research, Vol. 94, No. 11, 01.11.2015, p. 1516-1523.

Research output: Contribution to journalReview article

@article{9fb17fcf60424cbd84fbe357ccb19cdb,
title = "Targeting head and neck cancer stem cells: Current advances and future challenges",
abstract = "Cancer stem cells (CSCs), or tumor-initiating cells, comprise a subset of tumor cells with demonstrated ability for tumor growth, invasion, metastasis, and resistance to chemotherapy and radiation. Targeting of CSCs remains an attractive yet elusive therapeutic option, with the goal of increasing specificity and effectiveness in tumor eradication, as well as decreasing off-target or systemic toxicity. Research into further characterization and targeted therapy toward head and neck CSCs is an active and rapidly evolving field. This review discusses the current state of research into therapy against head and neck CSCs and future directions for targeted therapy.",
keywords = "cancer biology, cancer genes, characteristics, HNSCC, treatment, tumor initiating cells",
author = "Birkeland, {A. C.} and Owen, {J. H.} and Prince, {M. E.}",
year = "2015",
month = "11",
day = "1",
doi = "10.1177/0022034515601960",
language = "English (US)",
volume = "94",
pages = "1516--1523",
journal = "Journal of Dental Research",
issn = "0022-0345",
publisher = "SAGE Publications Inc.",
number = "11",

}

TY - JOUR

T1 - Targeting head and neck cancer stem cells

T2 - Current advances and future challenges

AU - Birkeland, A. C.

AU - Owen, J. H.

AU - Prince, M. E.

PY - 2015/11/1

Y1 - 2015/11/1

N2 - Cancer stem cells (CSCs), or tumor-initiating cells, comprise a subset of tumor cells with demonstrated ability for tumor growth, invasion, metastasis, and resistance to chemotherapy and radiation. Targeting of CSCs remains an attractive yet elusive therapeutic option, with the goal of increasing specificity and effectiveness in tumor eradication, as well as decreasing off-target or systemic toxicity. Research into further characterization and targeted therapy toward head and neck CSCs is an active and rapidly evolving field. This review discusses the current state of research into therapy against head and neck CSCs and future directions for targeted therapy.

AB - Cancer stem cells (CSCs), or tumor-initiating cells, comprise a subset of tumor cells with demonstrated ability for tumor growth, invasion, metastasis, and resistance to chemotherapy and radiation. Targeting of CSCs remains an attractive yet elusive therapeutic option, with the goal of increasing specificity and effectiveness in tumor eradication, as well as decreasing off-target or systemic toxicity. Research into further characterization and targeted therapy toward head and neck CSCs is an active and rapidly evolving field. This review discusses the current state of research into therapy against head and neck CSCs and future directions for targeted therapy.

KW - cancer biology

KW - cancer genes

KW - characteristics

KW - HNSCC

KW - treatment

KW - tumor initiating cells

UR - http://www.scopus.com/inward/record.url?scp=84945162698&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945162698&partnerID=8YFLogxK

U2 - 10.1177/0022034515601960

DO - 10.1177/0022034515601960

M3 - Review article

C2 - 26307039

AN - SCOPUS:84945162698

VL - 94

SP - 1516

EP - 1523

JO - Journal of Dental Research

JF - Journal of Dental Research

SN - 0022-0345

IS - 11

ER -